Gearing up to start an exercise program — especially for those over 40 — can be filled with pitfalls. Experts at UAB say start slow and low.
Research suggests that a class of drugs for rheumatoid arthritis seeking approval this year could be effective against other autoimmune diseases.
New research from UAB shows definitive link between a protein and cell activation; shutting both down could be a target of new treatments for cancer and autoimmune diseases.
Tigatuzumab, developed at UAB with Daiichi-Sankyo, targets aggressive, hard-to-treat tumors that make up 25 percent of all breast cancers